VENTURA, Calif., Nov. 24 /PRNewswire/ -- VivoMetrics, Inc., developer of
LifeShirt(R), a continuous, integrated and wearable remote patient monitoring
(RPM) system, announced today that the company's proprietary LifeShirt(R)
system is being used by
Children enrolled in the Healthy Heart Project at
Cardiovascular disease accounts for 32 percent of all deaths in Canada and 36 percent of all deaths in the United States. Almost 81 million adults (one in three) in the United States have one or more types of cardiovascular diseases. Results of the large histological Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study showed that the vascular injury that will lead to cardiovascular disease accumulates from adolescence, making primary prevention efforts necessary from childhood(1).
"LifeShirt provides a novel means of gaining critical insights into steps
we can take in childhood to fight a disease that accounts for the deaths of
more Canadians and Americans than any other disease," said lead researcher
Jennifer McGrath, Ph.D., M.P.H., assistant professor and director of the
Pediatric Public Health Psychology Lab at
LifeShirt(R) is a wearable, integrated RPM technology that continuously monitors multiple patient vital signs. The system provides researchers, physicians and healthcare providers with actionable insights into a patient's health via the monitoring and relational reporting of key life-sign functions including heart rate, respiratory rate, oxygen saturation, body position, activity level and skin temperature. LifeShirt(R) enables the comfortable collection of information in ambulatory and home settings with minimal effort by or disruption to the patient.
"The opportunity to partner with the team at Concordia to combat a health issue as vast as cardiovascular disease is a testament to the LifeShirt technology, already a proven asset in research conducted in real-life settings," said Howard Baker, president and chief executive officer of VivoMetrics. "As we develop our next generation system, VivoMetrics is uniquely positioned to expand more broadly into healthcare and address the needs of a population that is growing older and experiencing greater rates of chronic diseases. By providing a continuous and accurate picture of a patient's well-being outside of traditional hospital or clinical settings, we can enable healthcare providers to improve outcomes and reduce the overall cost of care."
The Healthy Heart Project is conducted by members of Team Prodigy, an
inter-university research team including Universite de Montreal,
VivoMetrics, Inc., founded in 1999 and based in Ventura, Calif., specializes in continuous ambulatory monitoring through the use of its proprietary LifeShirt(R) technology, enabling healthcare professionals and researchers to obtain a complete, real-time picture of a patient's physiological status in ambulatory and home settings. A wearable, completely non-invasive "smart garment," LifeShirt(R) monitors vital life-sign functions such as heart rate, respiratory rate, oxygen saturation, body position, activity level and skin temperature which, when monitored and reviewed in relation to one another, provide the most complete, real-time picture of a patient's physiologic status available today in an ambulatory form factor. VivoMetrics has supported research and clinical trials using LifeShirt(R) at nearly 300 leading research and academic institutions across a wide range of disease states, including sleep disordered breathing, congestive heart failure, chronic obstructive pulmonary disease and cystic fibrosis. For more information, visit http://www.lifeshirt.com.
This press release contains forward-looking statements, including but not limited to, those that refer to the company's future development plans. Actual results could differ materially from those anticipated due to numerous business, market and financial risk factors. The forward-looking statements in this press release represent our current views as of today and we disclaim any obligation to update these forward-looking statements in the future.
1. McGill HC, McMahan CA, Zieske AW, et al (Aug 2000). "Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group". Arterioscler Thromb Vasc Biol. 20 (8): 1998-2004. Media Contact: Vanessa Hughes Porter Novelli Life Sciences 310-444-7019 email@example.com
|SOURCE VivoMetrics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved